학술논문

1 . Academic Journal

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

저자: by Amos, Claire; Beaney, Katherine; Bellenger, Katharine; Brawley, Chris; Chung, Christina, et al.
소스: In The Lancet 1-7 June 2024 403(10442):2405-2415

7 . Academic Journal

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

저자: by Amos, Claire; Beaney, Katherine; Bellenger, Katharine; Brawley, Chris; Chung, Christina, et al.
소스: In The Lancet 1-7 June 2024 403(10442):2416-2425

7 . Academic Journal

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

저자: by Jones, Elin; Hyde, Katherine; Glen, Hilary; Needleman, Sarah; McGovern, Ursula, et al.
소스: In The Lancet Oncology May 2023 24(5):443-456

7 . Academic Journal

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol

저자: by Jones, Elin; Hyde, Katherine; Glen, Hilary; Needleman, Sarah; McGovern, Ursula, et al.
소스: In The Lancet 29 January-4 February 2022 399(10323):447-460

7 . Academic Journal

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.

저자: by Parker, Chris C; Kynaston, Howard; Cook, Adrian D; Clarke, Noel W; Catton, Charles N, et al.
소스: Lancet. Jun2024, Vol. 403 Issue 10442, p2416-2425. 10p.

7 . Periodical

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

저자: by Parker, Chris C; Clarke, Noel W; Cook, Adrian D; Kynaston, Howard; Catton, Charles N, et al.
소스: The Lancet; June 2024, Vol. 403 Issue: 10442 p2405-2415, 11p

7 . Academic Journal

MM-533 Low-Dose Belantamab Mafodotin (Belamaf) in Combination With Nirogacestat Versus Belamaf Monotherapy in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Phase 1/2 DREAMM-5 Platform Sub-Study 3

저자: by Callander, Natalie S.; Richardson, Paul G.; Hus, Marek; Ribrag, Vincent; Lopez, Joaquin Martinez, et al.
소스: In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S507-S508

7 . Academic Journal

POSTER: MM-533 Low-Dose Belantamab Mafodotin (Belamaf) in Combination With Nirogacestat Versus Belamaf Monotherapy in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Phase 1/2 DREAMM-5 Platform Sub-Study 3

저자: by Callander, Natalie S.; Richardson, Paul G.; Hus, Marek; Ribrag, Vincent; Lopez, Joaquin Martinez, et al.
소스: In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S224-S224

7 . Academic Journal

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.

저자: by Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Sachdeva, Ashwin; Jones, Craig, et al.
소스: Lancet Oncology. May2023, Vol. 24 Issue 5, p443-456. 14p.

7 . Academic Journal

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.

저자: by Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Cross, William; Jones, Robert J, et al.
소스: Lancet. 1/29/2022, Vol. 399 Issue 10323, p447-460. 14p.

공지

DAU Library